30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

AveXis Inc (AVXS)

Track

The most recent insider trading activity occurred on April 2, 2018, with multiple planned sales by executives including James J. Litalien, Andrew F. Knudten, and Brian K. Kaspar. These transactions involved a significant number of shares across various executive roles, indicating a coordinated divestment.
Stock chart
Ticker: AVXS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kaspar Brian K.
Chief Scientific Officer
7 sales — total 1,792,440 USD
Planned sale 2 Apr 2018
Value US$2,352,237.33 | Price 108.65 | Shares 87,035
Planned sale 2 Apr 2018
Value US$1,137,613.95 | Price 127.90 | Shares 18,246
Planned sale 2 Apr 2018
Value US$113,003.56 | Price 121.64 | Shares 929
Planned sale 2 Apr 2018
Value US$382,052.22 | Price 120.18 | Shares 3,179
Planned sale 2 Apr 2018
Value US$479,665.09 | Price 119.29 | Shares 4,021
Planned sale 2 Apr 2018
Value US$237,167.19 | Price 118.17 | Shares 2,007
Planned sale 2 Apr 2018
Value US$331,812.00 | Price 117.00 | Shares 2,836
Planned sale 2 Apr 2018
Value US$4,623,984.39 | Price 121.65 | Shares 36,536
Planned sale 2 Apr 2018
Value US$4,403,477.74 | Price 298.39 | Shares 61,617
Planned sale 2 Apr 2018
Value US$10,115.28 | Price 120.42 | Shares 84
Planned sale 2 Apr 2018
Value US$96,774.16 | Price 119.77 | Shares 808
Planned sale 2 Apr 2018
Value US$47,787.74 | Price 118.58 | Shares 403
Planned sale 2 Apr 2018
Value US$43,644.73 | Price 117.01 | Shares 373
Planned sale 2 Apr 2018
Value US$19,114.60 | Price 123.32 | Shares 155
Planned sale 2 Apr 2018
Value US$92,459.98 | Price 122.14 | Shares 757
Planned sale 2 Apr 2018
Value US$126,355.72 | Price 120.11 | Shares 1,052
Planned sale 2 Apr 2018
Value US$154,900.71 | Price 119.43 | Shares 1,297
Planned sale 2 Apr 2018
Value US$67,375.29 | Price 118.41 | Shares 569
Planned sale 2 Apr 2018
Value US$137,007.00 | Price 117.10 | Shares 1,170
Planned sale 7 Mar 2018
Value US$145,046.00 | Price 131.86 | Shares 1,100
Planned sale 7 Mar 2018
Value US$78,468.00 | Price 130.78 | Shares 600
Planned sale 7 Mar 2018
Value US$622,368.00 | Price 129.66 | Shares 4,800
Planned sale 7 Mar 2018
Value US$308,760.00 | Price 128.65 | Shares 2,400
Planned sale 7 Mar 2018
Value US$89,355.00 | Price 127.65 | Shares 700
Planned sale 7 Mar 2018
Value US$50,660.00 | Price 126.65 | Shares 400
Planned sale 1 Mar 2018
Value US$19,948.50 | Price 128.70 | Shares 155
Planned sale 1 Mar 2018
Value US$53,854.32 | Price 127.92 | Shares 421
Planned sale 1 Mar 2018
Value US$59,361.12 | Price 126.84 | Shares 468
Planned sale 1 Mar 2018
Value US$63,372.96 | Price 125.74 | Shares 504
Planned sale 1 Mar 2018
Value US$22,013.49 | Price 124.37 | Shares 177
Planned sale 1 Mar 2018
Value US$17,960.92 | Price 123.02 | Shares 146
Planned sale 1 Mar 2018
Value US$15,731.55 | Price 121.95 | Shares 129
Planned sale 1 Mar 2018
Value US$166,434.28 | Price 128.62 | Shares 1,294
Planned sale 1 Mar 2018
Value US$441,687.20 | Price 127.84 | Shares 3,455
Planned sale 1 Mar 2018
Value US$535,011.39 | Price 126.57 | Shares 4,227
Planned sale 1 Mar 2018
Value US$350,591.40 | Price 125.66 | Shares 2,790
Planned sale 1 Mar 2018
Value US$155,437.50 | Price 124.35 | Shares 1,250
Planned sale 1 Mar 2018
Value US$59,345.78 | Price 123.38 | Shares 481
Planned sale 1 Mar 2018
Value US$126,808.20 | Price 122.52 | Shares 1,035
Planned sale 1 Mar 2018
Value US$56,871.36 | Price 121.52 | Shares 468
Planned sale 1 Mar 2018
Value US$6,445.50 | Price 128.91 | Shares 50
Planned sale 1 Mar 2018
Value US$52,219.92 | Price 127.99 | Shares 408
Planned sale 1 Mar 2018
Value US$63,982.80 | Price 126.95 | Shares 504
Planned sale 1 Mar 2018
Value US$56,448.28 | Price 125.72 | Shares 449
Planned sale 1 Mar 2018
Value US$21,750.75 | Price 124.29 | Shares 175
Planned sale 1 Mar 2018
Value US$14,779.20 | Price 123.16 | Shares 120
Planned sale 1 Mar 2018
Value US$8,991.74 | Price 121.51 | Shares 74
Planned sale 1 Feb 2018
Value US$2,088.11 | Price 122.83 | Shares 17
Planned sale 1 Feb 2018
Value US$31,163.82 | Price 120.79 | Shares 258
Planned sale 1 Feb 2018
Value US$356.88 | Price 118.96 | Shares 3
Planned sale 1 Feb 2018
Value US$59,123.01 | Price 118.01 | Shares 501
Planned sale 1 Feb 2018
Value US$117,237.12 | Price 117.12 | Shares 1,001
Planned sale 1 Feb 2018
Value US$2,456.60 | Price 122.83 | Shares 20
Planned sale 1 Feb 2018
Value US$18,874.35 | Price 121.77 | Shares 155
Planned sale 1 Feb 2018
Value US$21,074.24 | Price 119.74 | Shares 176
Planned sale 1 Feb 2018
Value US$89,466.74 | Price 118.03 | Shares 758
Planned sale 1 Feb 2018
Value US$104,380.65 | Price 117.15 | Shares 891
Planned sale 1 Feb 2018
Value US$12,283.00 | Price 122.83 | Shares 100
Planned sale 1 Feb 2018
Value US$25,365.60 | Price 121.95 | Shares 208
Planned sale 1 Feb 2018
Value US$111,234.06 | Price 121.17 | Shares 918
Planned sale 1 Feb 2018
Value US$119,299.02 | Price 120.14 | Shares 993
Planned sale 1 Feb 2018
Value US$107,752.36 | Price 118.67 | Shares 908
Planned sale 1 Feb 2018
Value US$850,208.22 | Price 117.79 | Shares 7,218
Planned sale 1 Feb 2018
Value US$544,867.75 | Price 117.05 | Shares 4,655
Planned sale 16 Jan 2018
Value US$5,625.00 | Price 112.50 | Shares 50
Planned sale 16 Jan 2018
Value US$14,037.66 | Price 111.41 | Shares 126
Planned sale 16 Jan 2018
Value US$11,030.00 | Price 110.30 | Shares 100
Planned sale 16 Jan 2018
Value US$105,689.25 | Price 109.75 | Shares 963
Planned sale 16 Jan 2018
Value US$110,194.66 | Price 108.14 | Shares 1,019
Planned sale 16 Jan 2018
Value US$8,945.16 | Price 106.49 | Shares 84
Planned sale 16 Jan 2018
Value US$66,075.36 | Price 105.89 | Shares 624
Planned sale 16 Jan 2018
Value US$112,383.36 | Price 104.64 | Shares 1,074
Planned sale 16 Jan 2018
Value US$48,051.84 | Price 103.56 | Shares 464
Planned sale 16 Jan 2018
Value US$50,587.04 | Price 101.99 | Shares 496
Planned sale 2 Jan 2018
Value US$75,383.64 | Price 110.21 | Shares 684
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
87,035 -7.7%
108.65
US$2,352,237 		87,035 -7.7% 108.65 US$2,352,237
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
18,246 +33.5%
127.90
US$1,137,614 		18,246 +33.5% 127.90 US$1,137,614
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
70,629 -39.0%
452.45
US$2,814,718 		70,629 -39.0% 452.45 US$2,814,718
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
3,179 -0.2%
120.18
US$382,052 		3,179 -0.2% 120.18 US$382,052
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
4,021 -0.2%
119.29
US$479,665 		4,021 -0.2% 119.29 US$479,665
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
2,007 -0.1%
118.17
US$237,167 		2,007 -0.1% 118.17 US$237,167
2018-04-04 2018-04-02 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
2,836 -0.2%
117.00
US$331,812 		2,836 -0.2% 117.00 US$331,812
2018-04-04 2018-04-02 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
79 -0.9%
123.37
US$9,746 		79 -0.9% 123.37 US$9,746
2018-04-04 2018-04-02 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
253 -2.8%
122.19
US$30,914 		253 -2.8% 122.19 US$30,914
2018-04-04 2018-04-02 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
84 -0.9%
120.42
US$10,115 		84 -0.9% 120.42 US$10,115
2018-04-04 2018-04-02 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
808 -8.1%
119.77
US$96,774 		808 -8.1% 119.77 US$96,774
2018-04-04 2018-04-02 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
403 -3.9%
118.58
US$47,788 		403 -3.9% 118.58 US$47,788
2018-04-04 2018-04-02 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
373 -3.5%
117.01
US$43,645 		373 -3.5% 117.01 US$43,645
2018-04-04 2018-04-02 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer
155 -3.9%
123.32
US$19,115 		155 -3.9% 123.32 US$19,115
2018-04-04 2018-04-02 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer
757 -16.1%
122.14
US$92,460 		757 -16.1% 122.14 US$92,460
2018-04-04 2018-04-02 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer
1,052 -18.3%
120.11
US$126,356 		1,052 -18.3% 120.11 US$126,356
2018-04-04 2018-04-02 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer
1,297 -18.4%
119.43
US$154,901 		1,297 -18.4% 119.43 US$154,901
2018-04-04 2018-04-02 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer
569 -7.5%
118.41
US$67,375 		569 -7.5% 118.41 US$67,375
2018-04-04 2018-04-02 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer
1,170 -13.3%
117.10
US$137,007 		1,170 -13.3% 117.10 US$137,007
2018-03-09 2018-03-07 PlS Planned sale Nolan Sean P.

President & CEO

Executive Director
1,100 -100.0%
131.86
US$145,046 		1,100 -100.0% 131.86 US$145,046
2018-03-09 2018-03-07 PlS Planned sale Nolan Sean P.

President & CEO

Executive Director
600 -35.3%
130.78
US$78,468 		600 -35.3% 130.78 US$78,468
2018-03-09 2018-03-07 PlS Planned sale Nolan Sean P.

President & CEO

Executive Director
4,800 -73.8%
129.66
US$622,368 		4,800 -73.8% 129.66 US$622,368
2018-03-09 2018-03-07 PlS Planned sale Nolan Sean P.

President & CEO

Executive Director
2,400 -27.0%
128.65
US$308,760 		2,400 -27.0% 128.65 US$308,760
2018-03-09 2018-03-07 PlS Planned sale Nolan Sean P.

President & CEO

Executive Director
700 -7.3%
127.65
US$89,355 		700 -7.3% 127.65 US$89,355
2018-03-09 2018-03-07 PlS Planned sale Nolan Sean P.

President & CEO

Executive Director
400 -4.0%
126.65
US$50,660 		400 -4.0% 126.65 US$50,660
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
155 -3.0%
128.70
US$19,948 		155 -3.0% 128.70 US$19,948
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
421 -7.6%
127.92
US$53,854 		421 -7.6% 127.92 US$53,854
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
468 -7.7%
126.84
US$59,361 		468 -7.7% 126.84 US$59,361
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
504 -7.7%
125.74
US$63,373 		504 -7.7% 125.74 US$63,373
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
177 -2.6%
124.37
US$22,013 		177 -2.6% 124.37 US$22,013
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
146 -2.1%
123.02
US$17,961 		146 -2.1% 123.02 US$17,961
2018-03-05 2018-03-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain
129 -1.8%
121.95
US$15,732 		129 -1.8% 121.95 US$15,732
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
1,294 -0.1%
128.62
US$166,434 		1,294 -0.1% 128.62 US$166,434
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
3,455 -0.2%
127.84
US$441,687 		3,455 -0.2% 127.84 US$441,687
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
4,227 -0.2%
126.57
US$535,011 		4,227 -0.2% 126.57 US$535,011
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
2,790 -0.2%
125.66
US$350,591 		2,790 -0.2% 125.66 US$350,591
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
1,250 -0.1%
124.35
US$155,438 		1,250 -0.1% 124.35 US$155,438
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
481 -0.0%
123.38
US$59,346 		481 -0.0% 123.38 US$59,346
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
1,035 -0.1%
122.52
US$126,808 		1,035 -0.1% 122.52 US$126,808
2018-03-05 2018-03-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
468 -0.0%
121.52
US$56,871 		468 -0.0% 121.52 US$56,871
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
50 -100.0%
128.91
US$6,446 		50 -100.0% 128.91 US$6,446
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
408 -89.1%
127.99
US$52,220 		408 -89.1% 127.99 US$52,220
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
504 -52.4%
126.95
US$63,983 		504 -52.4% 126.95 US$63,983
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
449 -31.8%
125.72
US$56,448 		449 -31.8% 125.72 US$56,448
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
175 -11.0%
124.29
US$21,751 		175 -11.0% 124.29 US$21,751
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
120 -7.0%
123.16
US$14,779 		120 -7.0% 123.16 US$14,779
2018-03-05 2018-03-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
74 -4.2%
121.51
US$8,992 		74 -4.2% 121.51 US$8,992
2018-02-05 2018-02-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
17 -100.0%
122.83
US$2,088 		17 -100.0% 122.83 US$2,088
2018-02-05 2018-02-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
258 -93.8%
120.79
US$31,164 		258 -93.8% 120.79 US$31,164
2018-02-05 2018-02-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
3 -1.1%
118.96
US$357 		3 -1.1% 118.96 US$357
2018-02-05 2018-02-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
501 -64.3%
118.01
US$59,123 		501 -64.3% 118.01 US$59,123
2018-02-05 2018-02-01 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
1,001 -56.2%
117.12
US$117,237 		1,001 -56.2% 117.12 US$117,237
2018-02-05 2018-02-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
20 -0.4%
122.83
US$2,457 		20 -0.4% 122.83 US$2,457
2018-02-05 2018-02-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
155 -3.0%
121.77
US$18,874 		155 -3.0% 121.77 US$18,874
2018-02-05 2018-02-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
176 -3.3%
119.74
US$21,074 		176 -3.3% 119.74 US$21,074
2018-02-05 2018-02-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
758 -12.4%
118.03
US$89,467 		758 -12.4% 118.03 US$89,467
2018-02-05 2018-02-01 PlS Planned sale Knudten Andrew F.

SrVP/Manufacture&Supply Chain

Officer
891 -12.7%
117.15
US$104,381 		891 -12.7% 117.15 US$104,381
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
100 -0.0%
122.83
US$12,283 		100 -0.0% 122.83 US$12,283
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
208 -0.0%
121.95
US$25,366 		208 -0.0% 121.95 US$25,366
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
918 -0.1%
121.17
US$111,234 		918 -0.1% 121.17 US$111,234
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
993 -0.1%
120.14
US$119,299 		993 -0.1% 120.14 US$119,299
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
908 -0.1%
118.67
US$107,752 		908 -0.1% 118.67 US$107,752
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
7,218 -0.4%
117.79
US$850,208 		7,218 -0.4% 117.79 US$850,208
2018-02-05 2018-02-01 PlS Planned sale Kaspar Brian K.

Chief Scientific Officer

Executive Director
4,655 -0.3%
117.05
US$544,868 		4,655 -0.3% 117.05 US$544,868
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
50 -100.0%
112.50
US$5,625 		50 -100.0% 112.50 US$5,625
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
126 -71.6%
111.41
US$14,038 		126 -71.6% 111.41 US$14,038
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
100 -36.2%
110.30
US$11,030 		100 -36.2% 110.30 US$11,030
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
963 -77.7%
109.75
US$105,689 		963 -77.7% 109.75 US$105,689
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
1,019 -45.1%
108.14
US$110,195 		1,019 -45.1% 108.14 US$110,195
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
84 -3.6%
106.49
US$8,945 		84 -3.6% 106.49 US$8,945
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
624 -21.0%
105.89
US$66,075 		624 -21.0% 105.89 US$66,075
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
1,074 -26.6%
104.64
US$112,383 		1,074 -26.6% 104.64 US$112,383
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
464 -10.3%
103.56
US$48,052 		464 -10.3% 103.56 US$48,052
2018-01-18 2018-01-16 PlS Planned sale LITALIEN JAMES J

SrVP/Chief Reg&Quality Officer

Officer
496 -9.9%
101.99
US$50,587 		496 -9.9% 101.99 US$50,587
2018-01-04 2018-01-02 PlS Planned sale Nagendran Sukumar

Sr. VP & Chief Medical Officer

Officer
684 -100.0%
110.21
US$75,384 		684 -100.0% 110.21 US$75,384
Explore more

More insider trading research around AveXis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America